BioSpace News Archive

Drug Development

Ahead of ASCO, Bristol Myers Squibb Announces Results for Three Clinical Trials

Bristol Myers Squibb released new data from two clinical trials of Opdivo plus Yervoy-based combinations in non-small cell lung cancer and updated results from the KarMMa trial of ide-cel for multiple myeloma being developed with bluebird bio.

May 14, 2020
·
2 min read
·
Mark Terry
Biotech Beach

Research Roundup: 3-Drug Cocktail Decreases COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

May 14, 2020
·
6 min read
·
Mark Terry
Confronting the Challenges of Working at Home

Working from home, though appealing to many workers, has long presented a special set of challenges. Those challenges were magnified in the sudden boom of remote workers who took to their homes during the 2020 COVID-19 pandemic.

May 14, 2020
·
7 min read
·
Katharine Hansen, PhD
Business

“Game-Changing” Gene Therapy a Joint Effort by Urologist Consortium and FKD Therapies

A gene therapy that eliminates the need for radical cystectomies (complete removal of the bladder) in a particular, aggressive form of bladder cancer is undergoing Priority Review by the U.S. Food and Drug Administration.

May 14, 2020
·
4 min read
·
Gail Dutton
Business

BioSpace Movers & Shakers, May 15

Pharma, biotech and life sciences companies bolster their executive teams and boards with these Movers & Shakers.

May 14, 2020
·
4 min read
·
Alex Keown
Drug Development

Positive Phase III Results Keep Merck on Track to Compete with Roche in Triple-Negative Breast Cancer

The company announced positive data from the Phase III KEYNOTE-355 trial looking at Keytruda in combination with chemotherapy as first-line treatment for metastatic triple-negative breast cancer.

May 14, 2020
·
3 min read
·
Mark Terry
Policy

Biopharma Update on the Novel Coronavirus: May 14

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.

May 14, 2020
·
3 min read
·
BioSpace Editorial Staff
Deals

Legend Biotech Aims for $100 Million IPO

Legend Biotech, a clinical stage oncology biotech company, filed with the U.S. Securities and Exchange Commission on Wednesday to raise up to $100 million in an initial public offering.

May 14, 2020
·
3 min read
·
Krystle Vermes
Business

Former GSK Vaccines Executive Tapped to Helm White House’s ‘Operation Warp Speed’

Following the announcement that Slaoui was tapped to helm Operation Warp Speed, Jim Greenwood, president and CEO of BIO, hailed that decision.

May 14, 2020
·
3 min read
·
Alex Keown
Business

Abbott Questions Results of NYU Study Regarding Accuracy of COVID-19 Test

Researchers at a New York hospital compared Abbott’s 15-minute Abbott ID NOW test to another COVID-19 diagnostics device and found that the Abbott system missed 48% of positive cases the other device detected.

May 14, 2020
·
3 min read
·
Alex Keown